SCHEMBL29965137

SCHEMBL29965137

CN1CCC2(CC1)CCN(C(=O)Oc1ccc3ccc4ccccc4c3c1)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.51
CYP3A4 P08684 11/20 0.49
SMN1; SMN2 Q16637 9/20 0.49
ALDH1A1 P00352 8/20 0.49
MAPK1 P28482 7/20 0.49
TP53 P04637 1/20 0.49
CYP2D6 P10635 5/20 0.47
USP2 O75604 5/20 0.47
CYP1A2 P05177 4/20 0.46
HSD17B10 Q99714 2/20 0.46
CYP2C9 P11712 4/20 0.46
CYP2C19 P33261 3/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
HIF1A Q16665 2/20 0.45
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29965291 1.00 TSHR (0.51) TSHRCYP3A4SMN1; SMN2ALDH1A1MAPK1
SCHEMBL29965066 0.87 SMN1; SMN2 (0.54) TSHRCYP3A4SMN1; SMN2ALDH1A1MAPK1
SCHEMBL23199839 0.84 SMN1; SMN2 (0.52) TSHRCYP3A4SMN1; SMN2ALDH1A1TP53
Hydrochloric Acid SCHEMBL23199827 0.83 SMN1; SMN2 (0.51) TSHRCYP3A4SMN1; SMN2ALDH1A1TP53
SCHEMBL29965398 0.83 CYP3A4 (0.46) TSHRCYP3A4SMN1; SMN2ALDH1A1TP53
Trifluoroacetic Acid SCHEMBL31198241 0.79 CYP3A4 (0.46) TSHRCYP3A4SMN1; SMN2ALDH1A1MAPK1
SCHEMBL30628897 0.79 SMN1; SMN2 (0.50) TSHRCYP3A4SMN1; SMN2ALDH1A1TP53
SCHEMBL12467310 0.79 SMN1; SMN2 (0.50) TSHRCYP3A4SMN1; SMN2ALDH1A1TP53
SCHEMBL30628898 0.79 SMN1; SMN2 (0.50) TSHRCYP3A4SMN1; SMN2ALDH1A1TP53
SCHEMBL30489099 0.76 GAA (0.47) TSHRCYP3A4SMN1; SMN2TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151260-A Fulvestrant prodrugs 卡希夫生物科学有限公司 2022-10-04 CN disclosed